Status: Not yet recruiting
Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department
This study aims to compare the analgesic effectiveness and side effects of intranasal ketorolac at 30 mg Versus 20 mg for the Treatment of Acute moderate and severe Pain in the Emergency Department.
Participants needed: 100
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Tehran University of Medical SciencesUpdated: Sep 16, 2026
Eligibility criteria
Age: 18-65 years [+3]
Active peptic ulcer disease (PUD) [+26]